User profiles for Mirella Filocamo

Mirella Filocamo

G. Gaslini Institute, Genova, Italy
Verified email at gaslini.org
Cited by 7222

Germline mutations in HRAS proto-oncogene cause Costello syndrome

…, K Kurosawa, H Ohashi, Y Tanaka, M Filocamo… - Nature …, 2005 - nature.com
Costello syndrome is a multiple congenital anomaly and mental retardation syndrome
characterized by coarse face, loose skin, cardiomyopathy and predisposition to tumors. We …

[HTML][HTML] Lysosomal storage disorders: molecular basis and laboratory testing

M Filocamo, A Morrone - Human genomics, 2011 - Springer
Lysosomal storage disorders (LSDs) are a large group of more than 50 different inherited
metabolic diseases which, in the great majority of cases, result from the defective function of …

[HTML][HTML] GM1 gangliosidosis and Morquio B disease: an update on genetic alterations and clinical findings

…, A d'Amico, A d'Azzo, E Bertini, M Filocamo… - … et Biophysica Acta (BBA …, 2011 - Elsevier
GM1 gangliosidosis and Morquio B syndrome, both arising from beta-galactosidase (GLB1)
deficiency, are very rare lysosomal storage diseases with an incidence of about 1:100,000–1…

Ambroxol as a pharmacological chaperone for mutant glucocerebrosidase

I Bendikov-Bar, G Maor, M Filocamo… - Blood Cells, Molecules …, 2013 - Elsevier
Gaucher disease (GD) is characterized by accumulation of glucosylceramide in lysosomes
due to mutations in the GBA1 gene encoding the lysosomal hydrolase β-glucocerebrosidase (…

Mutation Update of ARSA and PSAP Genes Causing Metachromatic Leukodystrophy

…, G Amico, F Fumagalli, I Spiga, M Filocamo… - Human …, 2016 - Wiley Online Library
Metachromatic leukodystrophy is a neurodegenerative disorder characterized by progressive
demyelination. The disease is caused by variants in the ARSA gene, which codes for the …

[HTML][HTML] Unfolded protein response in Gaucher disease: from human to Drosophila

G Maor, S Rencus-Lazar, M Filocamo, H Steller… - Orphanet journal of rare …, 2013 - Springer
Background In Gaucher disease (GD), resulting from mutations in the GBA gene, mutant β-glucocerebrosidase
(GCase) molecules are recognized as misfolded in the endoplasmic …

Identification and characterization of 15 novel GALC gene mutations causing Krabbe disease

…, M Di Rocco, DN Cooper, M Filocamo - Human …, 2010 - Wiley Online Library
The characterization of the underlying GALC gene lesions was performed in 30 unrelated
patients affected by Krabbe disease, an autosomal recessive leukodystrophy caused by the …

[HTML][HTML] Pseudogene-mediated posttranscriptional silencing of HMGA1 can result in insulin resistance and type 2 diabetes

…, I Le Pera, B Arcidiacono, M Filocamo… - Nature …, 2010 - nature.com
Processed pseudogenes are non-functional copies of normal genes that arise by a process
of mRNA retrotransposition. The human genome contains thousands of pseudogenes; …

Characterization of the ERAD process of the L444P mutant glucocerebrosidase variant

I Bendikov-Bar, I Ron, M Filocamo… - Blood Cells, Molecules …, 2011 - Elsevier
A large number of mutations in the glucocerebrosidase gene (GBA gene), encoding the
lysosomal acid hydrolase glucocerebrosidase (GCase), lead to Gaucher disease (GD). The …

[HTML][HTML] Pharmacological enhancement of mutated α-glucosidase activity in fibroblasts from patients with Pompe disease

…, C Porto, F Donaudy, B Rossi, M Rossi, M Filocamo… - Molecular Therapy, 2007 - cell.com
We investigated the use of pharmacological chaperones for the therapy of Pompe disease,
a metabolic myopathy due to mutations of the gene encoding the lysosomal hydrolase α-…